Dr. Turaga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 Cedar Street
New Haven, CT 06520Phone+1 203-785-3577
Education & Training
- University of South Florida MorsaniFellowship, Complex General Surgical Oncology, 2008 - 2010
- Creighton University School of Medicine (Omaha)Residency, Surgery, 2003 - 2008
- All India Institute of Medical SciencesClass of 2002
Certifications & Licensure
- CT State Medical License 2022 - 2024
- IL State Medical License 2016 - 2023
- OR State Medical License 2021 - 2022
- WI State Medical License 2010 - 2017
- FL State Medical License 2009 - 2011
- PA State Medical License 2009 - 2009
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Clinical Trials
- Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma Start of enrollment: 2018 Oct 10
- Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Start of enrollment: 2025 Sep 30
- A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma Start of enrollment: 2021 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- When Benchmarks Fail Us: A Case Study in Cytoreductive Surgery.Varun V Bansal, Hunter D D Witmer, Christopher P Childers, David G Su, Kiran K Turaga
Annals of Surgical Oncology. 2025-01-01 - Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors.Philippos Apolinario Costa, Arshia Arora, Yannelys Fernandez, Irvin Yi, Baylee Bakkila
Cancer. 2025-01-01 - Mutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy.David G Su, Ankit Dhiman, Varun V Bansal, Yuanyuan Zha, Ardaman Shergill
JCO Precision Oncology. 2024-09-01
Journal Articles
- Estimating Surgical Risk for Patients with Severe ComorbiditiesMuneera R Kapadia, Elizabeth C Poli, Kiran K Turaga, JAMA
Press Mentions
- 6 Recent Moves from the Nation's Leading Cancer CentersJuly 25th, 2022
- New Opdivo/Yervoy Mesothelioma Clinical Trial Begins SoonOctober 7th, 2021
- Upfront HIPEC May up Survival in Ovarian CancerAugust 25th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: